These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2514364)

  • 61. Phenylalkylamine stimulants, hallucinogens, and designer drugs.
    Glennon RA
    NIDA Res Monogr; 1990; 105():154-60. PubMed ID: 1678860
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated.
    Nichols DE
    Front Psychiatry; 2022; 13():863088. PubMed ID: 35401275
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hypothesis: involvement of the serotonergic system in the clinical expression of monosymptomatic hypochondriasis.
    King BH
    Pharmacopsychiatry; 1990 Mar; 23(2):85-9. PubMed ID: 2187212
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of antiepileptic and antimyoclonic drugs on serotonin receptors in vitro.
    Pranzatelli MR
    Epilepsia; 1988; 29(4):412-9. PubMed ID: 2839332
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives).
    Luethi D; Widmer R; Trachsel D; Hoener MC; Liechti ME
    Eur J Pharmacol; 2019 Jul; 855():103-111. PubMed ID: 31063768
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Psychoactive drugs and human sexual behavior: the role of serotonergic activity.
    Meston CM; Gorzalka BB
    J Psychoactive Drugs; 1992; 24(1):1-40. PubMed ID: 1619520
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of para-methoxyamphetamine and 2,5-dimethoxyamphetamine on serotonergic mechanisms.
    Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):101-5. PubMed ID: 581302
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted alpha-alkylthioamphetamines.
    Cloonan SM; Keating JJ; Corrigan D; O'Brien JE; Kavanagh PV; Williams DC; Meegan MJ
    Bioorg Med Chem; 2010 Jun; 18(11):4009-31. PubMed ID: 20466553
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives.
    Kline TB; Benington F; Morin RD; Beaton JM; Glennon RA; Domelsmith LN; Houk KN; Rozeboom MD
    J Med Chem; 1982 Nov; 25(11):1381-3. PubMed ID: 6815326
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Amphetamine Derivatives as Monoamine Oxidase Inhibitors.
    Reyes-Parada M; Iturriaga-Vasquez P; Cassels BK
    Front Pharmacol; 2019; 10():1590. PubMed ID: 32038257
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.
    Ohuoha DC; Hyde TM; Kleinman JE
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S5-15. PubMed ID: 7831440
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drugs affecting serotonin neurons.
    Fuller RW
    Prog Drug Res; 1990; 35():85-108. PubMed ID: 2149771
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Profile of in vitro binding affinities of neuroleptics at different rat brain receptors: cluster analysis comparison with pharmacological and clinical profiles.
    Testa R; Abbiati G; Ceserani R; Restelli G; Vanasia A; Barone D; Gobbi M; Mennini T
    Pharm Res; 1989 Jul; 6(7):571-7. PubMed ID: 2571988
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induced fit, ensemble binding space docking and Monte Carlo simulations of MDMA 'ecstasy' and 3D pharmacophore design of MDMA derivatives on the human serotonin transporter (hSERT).
    Islas ÁA; Moreno LG; Scior T
    Heliyon; 2021 Aug; 7(8):e07784. PubMed ID: 34458620
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and Evaluation of [
    Zeng F; Nye JA; Voll RJ; Mun J; Goodman MM
    Front Neurosci; 2021; 15():766320. PubMed ID: 34899169
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Functional activity of 5-HT2 receptors in the modulation of the sleep/wakefulness states.
    Dugovic C
    J Sleep Res; 1992 Sep; 1(3):163-168. PubMed ID: 10607046
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differentiation of amphetamine and its major hallucinogenic derivatives using thin-layer chromatography.
    O'Brien BA; Bonicamp JM; Jones DW
    J Anal Toxicol; 1982; 6(3):143-7. PubMed ID: 7109558
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Possible interactions between alkoxy amphetamines and brain serotonin receptors.
    Guion RR
    J Theor Biol; 1981 Jul; 91(1):237-9. PubMed ID: 7300385
    [No Abstract]   [Full Text] [Related]  

  • 79. Cardiovascular toxicity of novel psychoactive drugs: lessons from the past.
    Dawson P; Moffatt JD
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):244-52. PubMed ID: 22580238
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sugar derivatives of indolamines. Part IV: dissociation between the affinity of desoxyribulo-serotonin towards D and M type tryptaminergic receptors and study of its effect on platelet functions.
    Mester L; Launay JM; Mester M; Labrid C; Dureng G
    Thromb Res; 1979 Jan; 14(1):199-207. PubMed ID: 425080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.